What are the differential diagnoses for a woman who, after completing clindamycin cream for bacterial vaginosis, developed thick white‑to‑yellow (occasionally green) vaginal discharge, vulvar burning, and pain with vaginal suppository insertion, with partial improvement after a 150 mg dose of fluconazole and a 125 mg methylprednisolone injection but recurrence of symptoms three days later?

Differential Diagnoses for Recurrent Vulvovaginal Symptoms After Initial Candida Treatment

Your patient most likely has either recurrent vulvovaginal candidiasis (possibly complicated or non-albicans species), residual/recurrent bacterial vaginosis, or a non-infectious inflammatory condition such as desquamative inflammatory vaginitis or cytolytic vaginosis.

Key Diagnostic Considerations

1. Recurrent or Complicated Vulvovaginal Candidiasis

• The negative PCR does not rule out active candidiasis, because up to 20% of asymptomatic women are colonized with Candida species, and PCR cannot distinguish colonization from infection 1.
• Single-dose fluconazole (150 mg) is inadequate for severe or complicated vulvovaginal candidiasis; the IDSA guidelines recommend fluconazole 150 mg every 72 hours for 2–3 doses for severe acute disease 2.
• The thick white-to-yellow discharge with vulvar burning and pain on suppository insertion are classic for VVC, particularly when symptoms recur after brief improvement 2.
• Non-albicans species (especially C. glabrata) are often azole-resistant and require alternative therapy such as intravaginal boric acid 600 mg daily for 14 days 2.

2. Recurrent or Persistent Bacterial Vaginosis

• Clindamycin cream can fail in 40–50% of cases within weeks, and the green-tinged discharge raises concern for residual BV or mixed infection 3, 4.
• BV recurrence occurs in 50–80% of women within one year of antibiotic treatment because beneficial Lactobacillus species fail to recolonize the vagina 5.
• The methylprednisolone injection may have temporarily suppressed inflammation but does not treat the underlying microbial imbalance, explaining the rapid symptom return 4.

3. Desquamative Inflammatory Vaginitis (DIV)

• DIV presents with purulent yellow-green discharge, vulvar burning, dyspareunia, and elevated vaginal pH (>4.5), often misdiagnosed as recurrent candidiasis 3, 4.
• Microscopy shows abundant polymorphonuclear leukocytes and parabasal cells with few lactobacilli, distinguishing it from VVC 3.
• DIV responds to topical clindamycin 2% cream nightly for 2 weeks plus hydrocortisone 10% cream, not to antifungals 3, 4.

4. Cytolytic Vaginosis

• Cytolytic vaginosis mimics VVC with thick white discharge, vulvar burning, and normal pH (3.8–4.2), but wet mount shows abundant lactobacilli and lysed epithelial cells without yeast 1.
• Treatment involves alkalinization with sodium bicarbonate sitz baths, not antifungals 4.

5. Mixed Infection (BV + Candida)

• The combination of yellow-green discharge (BV) and thick white discharge (Candida) suggests coinfection, which is common after antibiotic treatment for BV 6, 3.

---

Recommended Diagnostic Work-Up

Immediate Office Testing

• Measure vaginal pH: pH 3.8–4.5 favors VVC or cytolytic vaginosis; pH >4.5 suggests BV, DIV, or trichomoniasis 1.
• Perform wet-mount microscopy with saline and 10% KOH: look for yeast forms/pseudohyphae (VVC), clue cells (BV), abundant lactobacilli with lysed cells (cytolytic vaginosis), or parabasal cells with leukocytes (DIV) 2, 1.
• Whiff test (KOH amine test): positive in BV, negative in VVC and DIV 3, 7.

Laboratory Confirmation

• Order fungal culture with speciation and antifungal susceptibility testing to detect non-albicans Candida (especially C. glabrata) and azole resistance 2, 1.
• Consider repeat nucleic acid amplification testing (NAAT) for Trichomonas vaginalis if pH is elevated, although sexual abstinence makes this less likely 1, 6.
• Gram stain of vaginal fluid is the gold standard for BV diagnosis if Amsel criteria are equivocal 3, 7.

---

Treatment Algorithm Based on Findings

If Yeast Forms Present on Microscopy or Culture-Confirmed VVC

• For C. albicans with severe or recurrent disease: fluconazole 150 mg every 72 hours for 2–3 doses, then consider maintenance therapy with fluconazole 150 mg weekly for 6 months 2.
• For C. glabrata or azole-resistant species: intravaginal boric acid 600 mg in gelatin capsules daily for 14 days 2, 4.
• Alternative for C. glabrata: nystatin intravaginal suppositories 100,000 units daily for 14 days 2.

If Clue Cells or Elevated pH Without Yeast

• Treat for recurrent BV: oral metronidazole 500 mg twice daily for 7 days or intravaginal metronidazole gel 0.75% nightly for 5 days 3, 4.
• Consider male-partner treatment (metronidazole 400 mg plus clindamycin 2% cream to penile skin, both twice daily for 7 days) to reduce recurrence risk by 28% 8.
• Maintenance therapy: metronidazole gel twice weekly for 4–6 months or vaginal Lactobacillus crispatus probiotics 4, 5.

If Abundant Leukocytes, Parabasal Cells, and Elevated pH

• Treat for desquamative inflammatory vaginitis: clindamycin 2% vaginal cream nightly for 2 weeks plus hydrocortisone 10% cream to vulva 3, 4.

If Abundant Lactobacilli, Lysed Cells, and Normal pH

• Treat for cytolytic vaginosis: sodium bicarbonate sitz baths (4 tablespoons in shallow bath water) twice daily for 1 week 4.

---

Common Pitfalls to Avoid

• Do not rely solely on PCR results: a negative PCR does not exclude active candidiasis, and a positive PCR does not confirm infection in the absence of symptoms 1.
• Do not prescribe empiric antifungals without microscopy or culture confirmation: this occurs in >55% of cases and promotes resistance 1.
• Do not use single-dose fluconazole for severe or recurrent VVC: this is inadequate per IDSA guidelines 2.
• Do not ignore the possibility of non-albicans Candida: C. glabrata accounts for 10–20% of VVC cases and requires non-azole therapy 2.
• Do not assume corticosteroids treat the underlying infection: methylprednisolone only masks inflammation and may worsen fungal or bacterial overgrowth 4.
• Do not overlook mixed infections: BV and VVC frequently coexist, especially after antibiotic treatment 6, 3.